Associations of factor VIIIc, D‐dimer, and plasmin–antiplasmin with incident cardiovascular disease and all‐cause mortality

To examine the associations of three understudied hemostatic factors—D‐dimer, factor VIIIc, and plasmin‐antiplasmin (PAP) complex—with incident cardiovascular disease (CVD) and all cause mortality in the Multiethnic Study of Atherosclerosis cohort. Hemostatic factors were measured at baseline in 45–84‐year‐old patients (n = 6,391) who were free of clinically recognized CVD. Over 4.6 years of follow‐up, we identified 307 CVD events, 207 hard coronary heart disease events, and 210 deaths. D‐dimer, factor VIIIc, and PAP were not associated with CVD incidence after adjustment for other risk factors. In contrast, each factor was associated positively with total mortality, and D‐dimer and factor VIIIc were associated positively with cancer mortality. When modeled as ordinal variables and adjusted for risk factors, total mortality was greater by 33% (95% CI 15–54) for each quartile increment of D‐dimer, 26% (11–44) for factor VIIIc, and 20% (4–38) for PAP. This prospective cohort study did not find D‐dimer, factor VIIIc, or PAP to be risk factors for CVD. Instead, elevated levels of these three hemostatic factors were associated independently with increased risk of death. Elevated D‐dimer and factor VIIIc were associated with increased cancer death. Am. J. Hematol., 2009. © 2009 Wiley‐Liss, Inc.

[1]  R. Medcalf,et al.  Fibrinolysis, inflammation, and regulation of the plasminogen activating system , 2007, Journal of thrombosis and haemostasis : JTH.

[2]  A. Reiner,et al.  Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study , 2007, Journal of thrombosis and haemostasis : JTH.

[3]  G. Lippi,et al.  Pathogenesis, clinical and laboratory aspects of thrombosis in cancer , 2007, Journal of Thrombosis and Thrombolysis.

[4]  G. Lowe,et al.  Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture * , 2006, British journal of haematology.

[5]  G. Lowe,et al.  Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study , 2005, Circulation.

[6]  H Tunstall-Pedoe,et al.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.

[7]  S. Humphries,et al.  Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway , 2004, Journal of thrombosis and haemostasis : JTH.

[8]  M. De Cicco The prothrombotic state in cancer: pathogenic mechanisms. , 2004, Critical reviews in oncology/hematology.

[9]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[10]  A. Falanga,et al.  Molecular basis for the relationship between thrombosis and cancer. , 2001, Thrombosis research.

[11]  J. Danesh,et al.  Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.

[12]  G. Lowe,et al.  Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study , 1999, British journal of haematology.

[13]  A. Sharrett,et al.  Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[14]  L. Kuller,et al.  Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[15]  A. Folsom,et al.  Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Circulation.

[16]  H. Gralnick,et al.  Coagulation disorders in cancer. , 1996, Hematology/oncology clinics of North America.

[17]  R. Detrano,et al.  Offline assessment of atherosclerotic coronary calcium from electron beam tomograms. , 1995, American journal of cardiac imaging.

[18]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[19]  J. Cooper,et al.  Factor VIII, ABO blood group and the incidence of ischaemic heart disease , 1994, British journal of haematology.

[20]  A. Folsom,et al.  Associations of Factor VIII and von Willebrand Factor with Age, Race, Sex, and Risk Factors for Atherosclerosis , 1993, Thrombosis and Haemostasis.

[21]  B M Psaty,et al.  Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1991, Stroke.

[22]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[23]  P. Holvoet,et al.  An Enzyme-Linked Immunosorbent Assay (ELISA) for the Measurement of Plasmin-α2-Antiplasmin Complex in Human Plasma - Application to the Detection of In Vivo Activation of the Fibrinolytic System , 1986, Thrombosis and Haemostasis.

[24]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[25]  Oxon Dm Obituary. Rupert Samuel Bruce Pearson. , 1974 .